Exact Mass: 458.1471
Exact Mass Matches: 458.1471
Found 500 metabolites which its exact mass value is equals to given mass value 458.1471
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Raltitrexed
Raltitrexed is only found in individuals that have used or taken this drug. It is a chemotherapy drug manufactured AstraZeneca Company, is an antimetabolite used in chemotherapy. It is an inhibitor of thymidylate synthase.Raltitrexed is an antineoplastic Agents and folic acid antagonists. Raltitrexed inhibits thymidylate synthase (TS) leading to DNA fragmentation and cell death. It is transported into cells via a reduced folate carrier. Inside the cell Raltitrexed is extensively polyglutamated, which enhances thymidylate synthase inhibitory power and duration. Inhibition of this enzyme results in decreased synthesis of thymidine triphosphate which is required for DNA synthesis. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BA - Folic acid analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2021 - Thymidylate Synthase Inhibitor D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents Same as: D01064
FMNH2
FMNH2 is the reduced form of flavin mononucleotide. It is a substrate of the enzyme FMN reductase (EC 1.5.1.29), an enzyme that catalyzes the chemical reaction FMNH2 + NAD(P)+ <=> FMN + NAD(P)H + H+. Flavin mononucleotide (FMN), or riboflavin-5′-phosphate, is a biomolecule produced from riboflavin (vitamin B2) by the enzyme riboflavin kinase and functions as prosthetic group of various oxidoreductases including NADH dehydrogenase. During a catalytic cycle, the reversible interconversion of oxidized (FMN), semiquinone (FMNH•) and reduced (FMNH2) forms occurs in the various oxidoreductases. FMN is a stronger oxidizing agent than NAD and is particularly useful because it can take part in both one- and two-electron transfers. FMNH is a substrate for 2,4-dienoyl-CoA reductase (mitochondrial). [HMDB]
I-123 BMIPP
C1446 - Radiopharmaceutical Compound > C2124 - Radioconjugate Same as: D06608
5a,11a-Dehydrooxytetracycline
A member of the class of tetracyclines with formula C22H22N2O9 that is an intermediate in the biosynthesis of oxytetracycline by Streptomyces rimosus.
Valechlorin
Constituent of Valeriana officinalis (valerian). Valechlorin is found in tea, fats and oils, and herbs and spices. Valechlorin is found in fats and oils. Valechlorin is a constituent of Valeriana officinalis (valerian). Valechlorin is an iridoid monoterpenoid.
Deoxynivalenol 3-glucoside
Deoxynivalenol 3-glucoside is found in cereals and cereal products. Deoxynivalenol 3-glucoside is isolated from cultures of sweet corn (Zea mays). Isolated from cultures of sweet corn (Zea mays). Deoxynivalenol 3-glucoside is found in cereals and cereal products and fats and oils.
6'-O-Acetyldaidzin
Isolated from soybean seeds (Glycine max); potential nutriceutical. 6-Acetyldaidzin is found in many foods, some of which are soy yogurt, miso, soy milk, and soy bean. 6-O-Acetyldaidzin is found in miso. 6-O-Acetyldaidzin is isolated from soybean seeds (Glycine max); potential nutriceutica
2'-(E)-Feruloyl-3-(arabinosylxylose)
2-(E)-Feruloyl-3-(arabinosylxylose) is found in cereals and cereal products. 2-(E)-Feruloyl-3-(arabinosylxylose) is isolated from corn hull
a-L-Fucopyranosyl-(1->2)-b-D-galactopyranosyl-(1->2)-D-xylose
a-L-Fucopyranosyl-(1->2)-b-D-galactopyranosyl-(1->2)-D-xylose is found in pulses. a-L-Fucopyranosyl-(1->2)-b-D-galactopyranosyl-(1->2)-D-xylose is a constituent in the cell wall material of scarlet runner bean (Phaseolus coccineus). Constituent in the cell wall material of scarlet runner bean (Phaseolus coccineus). a-L-Fucopyranosyl-(1->2)-b-D-galactopyranosyl-(1->2)-D-xylose is found in pulses.
7-Hydroxy-4-methylphthalide O-[arabinosyl-(1->6)-glucoside]
7-Hydroxy-4-methylphthalide O-[arabinosyl-(1->6)-glucoside] is a constituent of the bark of Quillaja saponaria (soap-bark tree). Constituent of the bark of Quillaja saponaria (soap-bark tree)
cis-p-Coumaric acid 4-[apiosyl-(1->2)-glucoside]
cis-p-Coumaric acid 4-[apiosyl-(1->2)-glucoside] is found in herbs and spices. cis-p-Coumaric acid 4-[apiosyl-(1->2)-glucoside] is a constituent of Salvia officinalis (sage). Constituent of Salvia officinalis (sage). cis-p-Coumaric acid 4-[apiosyl-(1->2)-glucoside] is found in tea and herbs and spices.
3-Hydroxychavicol 1-[rhamnosyl-(1->6)-glucoside]
3-Hydroxychavicol 1-[rhamnosyl-(1->6)-glucoside] is found in herbs and spices. 3-Hydroxychavicol 1-[rhamnosyl-(1->6)-glucoside] is a constituent of rhizomes of Alpinia officinarum (lesser galangal). Constituent of rhizomes of Alpinia officinarum (lesser galangal). 3-Hydroxychavicol 1-[rhamnosyl-(1->6)-glucoside] is found in herbs and spices.
Eugenol O-[a-L-Arabinofuranosyl-(1->6)-b-D-glucopyranoside]
Eugenol O-[a-L-Arabinofuranosyl-(1->6)-b-D-glucopyranoside] is found in green vegetables. Eugenol O-[a-L-Arabinofuranosyl-(1->6)-b-D-glucopyranoside] is a constituent of Rosa damascena (damask rose). Constituent of Rosa damascena (damask rose). Eugenol O-[a-L-Arabinofuranosyl-(1->6)-b-D-glucopyranoside] is found in herbs and spices and green vegetables.
12-Hydroxynevirapine glucuronide
12-Hydroxynevirapine glucuronide is a metabolite of nevirapine. Nevirapine, also marketed under the trade name Viramune, is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat HIV-1 infection and AIDS. As with other antiretroviral drugs, HIV rapidly develops resistance if nevirapine is used alone, so recommended therapy consists of combinations of three or more antiretrovirals. (Wikipedia)
2-Hydroxynevirapine glucuronide
2-Hydroxynevirapine glucuronide is a metabolite of nevirapine. Nevirapine, also marketed under the trade name Viramune, is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat HIV-1 infection and AIDS. As with other antiretroviral drugs, HIV rapidly develops resistance if nevirapine is used alone, so recommended therapy consists of combinations of three or more antiretrovirals. (Wikipedia)
3-Hydroxynevirapine glucuronide
3-Hydroxynevirapine glucuronide is a metabolite of nevirapine. Nevirapine, also marketed under the trade name Viramune, is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat HIV-1 infection and AIDS. As with other antiretroviral drugs, HIV rapidly develops resistance if nevirapine is used alone, so recommended therapy consists of combinations of three or more antiretrovirals. (Wikipedia)
8-Hydroxynevirapine glucuronide
8-Hydroxynevirapine glucuronide is a metabolite of nevirapine. Nevirapine, also marketed under the trade name Viramune, is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat HIV-1 infection and AIDS. As with other antiretroviral drugs, HIV rapidly develops resistance if nevirapine is used alone, so recommended therapy consists of combinations of three or more antiretrovirals. (Wikipedia)
Lorglumide
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
10,14-Dihydroxy-11-methoxy-3,3-dimethyl-12-(3-methyl-2-butenyl)-[1]benzopyrano[5,6-b]xanthen-13(3H)-one
MulberrosideC
Mulberroside C is a natural product found in Morus lhou, Morus wittiorum, and Morus alba with data available. Mulberroside C is one of the main bioactive constituents in mulberry (Morus alba L.)[1]. Mulberroside C is a HCV replicon inhibitor. Antiviral activity[2]. Mulberroside C is one of the main bioactive constituents in mulberry (Morus alba L.)[1]. Mulberroside C is a HCV replicon inhibitor. Antiviral activity[2].
7-Hydroxy-5,4-dimethoxy-8-methylisoflavone 7-O-rhamnoside
[3aS-[3aR*,4R*,5S*(Z),6S*,10Z,11aS*]]-2,3,3a,4,5,6,7,11a-Octahydro-10-(hydroxymethyl)-6-methyl-3-methylene-4-[(2-methyl-1-oxo-2-propenyl)oxy]-2,7-dioxo-6,9-epoxycyclodeca[b]furan-5-yl ester 2-methyl-2-butenoic acid
[3aS-(3aR*,4R*,5S*,6S*,10Z,11aS*)]-2,3,3a,4,5,6,7,11a-Octahydro-10-(hydroxymethyl)-6-methyl-3-methylene-4-[(2-methyl-1-oxo-2-propenyl)oxy]-2,7-dioxo-6,9-epoxycyclodeca[b]furan-5-yl ester 3-methyl-2-butenoic acid
Chrysin 7-(4-acetylglucoside)
6-O-Acetyldaidzin
6,6,7,8-Tetra-Me ether,di-Ac-2,5,6,6,7,8-Hexahydroxyflavone
8-O-beta-D-(6-O-acetyl)glucopyranosyl-chrysophanol|8-O-??-D-(6-O-Acetyl)glucopyranosylchrysophanol|chrysophanol-8-O-beta-D-(6-O-acetyl)glucopyranoside|emodin-8-O-beta-D-((6)-O-acetyl)glucopyranoside
Benzyl glycoside,2-Ac-beta-Pyranose-3-O-alpha-L-Rhamnopyranosyl-D-galactose
alpha-D-Glcp-(1->4)-6-O-(1-L-maloyl)-alpha/beta-D-Glcp|veracylglucan B
6-acetoxy-1-hydroxy-2-methylanthraquinone-3-O-alpha-L-rhamnopyranoside|rubiacordone A
(Z)-1-O-p-Coumaroyl-beta-D-xylopyranosyl-(1->6)-beta-D-glucopyranose
rel-5-(3S,8S-dihydroxy-1R,5S-dimethyl-7-oxa-6-oxobicyclo[3,2,1]oct-8-yl)-3-methyl-2Z,4E-pentadienoic acid 3-O-beta-D-glucopyranoside
1-O-(6-O-alpha-L-rhamnopyranosyl-beta-D-glucopyranosyl)-2-hydroxy-4-allylbenzene|3,4-Dihydroxyallylbenzene 4-O-[??-L-rhamnopyranosyl-(1鈥樏傗垎6)]-??-D-glucopyranoside|demethyleugenol beta-rutinoside
(1R,2S,4S,5S,6R,7R,9S,10S)-1,9,15-triacetoxy-2,4,6-trihydroxy-8-oxodihydro-beta-agarofuran
(2E)-2-decene-4,6-diyne-1,8-diol 8-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside|(2E)-2-Decene-4,6-diyne-1,8-diol 8-O-??-D-apiofuranosyl-(1鈥樏傗垎6)-??-D-glucopyranoside
<2-O-(trans-feruloyl)-alpha-L-arabinofuranosyl>-(1->5)-L-arabinofuranose|O-(2-O-trans-feruloyl-alpha-L-arabinofuranosyl)-(1<*>5)-alpha-L-arabinofuranose|O-(2-O-trans-feruloyl-alpha-L-arabinofuranosyl)-(1[*]5)-alpha-L-arabinofuranose|O-[2-O-(trans-feruloyl)-alpha-L-arabinofuranosyl]-(1-5)-L-arabinofuranose
7-O-beta-D-[(6-acetyl)glucopyranosyl]chrysin|chrysin 7-(6-O-acetyl)-O-beta-D-glucopyranoside
4-allyl-2-methoxyphenyl 6-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside|4-allyl-2-methoxyphenyl-O-beta-D-apiosyl-(1->6)-beta-D-glucopyranoside
2-O-<5-O-(trans-feruloyl)-beta-L-arabinofuranosyl>-D-xylopyranose|2-O-[5-O-(trans-feruloyl)-beta-L-arabinofuranosyl]-D-xylopyranose
1-O-(2-methoxy-4-acetylphenyl)-6-O-(E-cinnamoyl)-beta-D-glucopyranoside|scrophuloside C
methyl 3-O-beta-D-glucopyranosyl-6?-O-caffeoyl-(3R)-4-hydroxybutanoate
(6-cis-p-coumaroyl)-3-O-beta-D-glucopyranosyl-2-deoxy-D-ribonic acid
4-Allyl-2-methoxyphenyl 6-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside
4-methoxy-cinnamyl-(6-O-alpha-L-arabinopyranosyl)-O-beta-D-glucopyranoside|4-methoxycinnamyl 6-O-(alpha-L-arabinopyranosyl)-beta-D-glucopyranoside
1-(beta-D-glucopyranosyloxybenzyl)-2-hydroxy-2-isopropyl-malate methyl ester
piperchabaoside A|trans-cinnamyl alcohol O-beta-D-glucopyranosyl-(1->4)-beta-D-glucopyranoside
1,6-dihydroxy-7-methoxy-8-(3-methyl-2-butenyl)-2,2-dimethylchromeno[5,6:2,3]xanthone
5-O-[(E)-feruloyl]-O-[beta-D-xylopyranosyl-(1->2)]-L-arabinofuranose|beta-D-xylopyranosyl-(1->2)-5-O-trans-feruloyl-L-arabinofuranose
1-(4-beta-D-glucopyranosyloxybenzyl)-(2R)-2-isobutylmalate|4-{{[(2R)-2-(carboxymethyl)-2-hydroxy-4-methyl-1-oxopentyl]oxy}methyl}phnyl beta-D-glucopyranoside|gymnoside I
4-(4-beta-D-glucopyranosyloxybenzyl)-(2R)-2-isobutylmalanate|4-{{[(3R)-3-carboxy-3-hydroxy-5-methyl-1-oxohexyl]oxy}methyl}phenyl beta-D- glucopyranoside|gymnoside II
6-trans-<2-O-(alpha-rhamnopyranosyl)>-ethenyl-5,7,4-trihydroxyflavone|drymariatin A
5-[2,3-epoxy-3-methylbutyl]-3-O-beta-D-xylopyranosyl-6,5-dihydroxy-2-phenylbenzofuran|moracinoside M
His Thr Ser Asp
(±)-Phrymarolin II
5-(6-acetyloxy-3,5,7-trimethoxy-4-oxochromen-2-yl)-2-methoxyphenyl acetate
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.247 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.248
2-(hydroxymethyl)-6-[[3,4,5-trihydroxy-6-(4-prop-2-enylphenoxy)oxan-2-yl]methoxy]oxane-3,4,5-triol
Raltitrexed
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BA - Folic acid analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2021 - Thymidylate Synthase Inhibitor D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents
Deoxynivalenol 3-glucoside
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins CONFIDENCE Reference Standard (Level 1)
Ala Cys Cys Tyr
Ala Cys Glu His
Ala Cys His Glu
Ala Cys Tyr Cys
Ala Glu Cys His
Ala Glu His Cys
Ala His Cys Glu
Ala His Glu Cys
Ala Tyr Cys Cys
Cys Ala Cys Tyr
Cys Ala Glu His
Cys Ala His Glu
Cys Ala Tyr Cys
Cys Cys Ala Tyr
Cys Cys Phe Ser
Cys Cys His Pro
Cys Cys Pro His
Cys Cys Ser Phe
Cys Cys Tyr Ala
Cys Glu Ala His
Cys Glu His Ala
Cys Phe Cys Ser
Cys Phe Ser Cys
Cys His Ala Glu
Cys His Cys Pro
Cys His Glu Ala
Cys His Pro Cys
Cys Pro Cys His
Cys Pro His Cys
Cys Ser Cys Phe
Cys Ser Phe Cys
Cys Ser Ser Tyr
Cys Ser Tyr Ser
Cys Tyr Ala Cys
Cys Tyr Cys Ala
Cys Tyr Ser Ser
Asp Gly His Met
Asp Gly Met His
Asp His Gly Met
Asp His Met Gly
Asp His Ser Thr
Asp His Thr Ser
Asp Met Gly His
Asp Met His Gly
Asp Asn Asn Pro
Asp Asn Pro Asn
Asp Pro Asn Asn
Asp Ser His Thr
Asp Ser Thr His
Asp Thr His Ser
Asp Thr Ser His
Glu Ala Cys His
Glu Ala His Cys
Glu Cys Ala His
Glu Cys His Ala
Glu His Ala Cys
Glu His Cys Ala
Glu His Ser Ser
Glu Ser His Ser
Glu Ser Ser His
Phe Cys Cys Ser
Phe Cys Ser Cys
Phe Ser Cys Cys
Gly Asp His Met
Gly Asp Met His
Gly His Asp Met
Gly His Met Asp
Gly Met Asp His
Gly Met His Asp
His Ala Cys Glu
His Ala Glu Cys
His Cys Ala Glu
His Cys Cys Pro
His Cys Glu Ala
His Cys Pro Cys
His Asp Gly Met
His Asp Met Gly
His Asp Ser Thr
His Asp Thr Ser
His Glu Ala Cys
His Glu Cys Ala
His Glu Ser Ser
His Gly Asp Met
His Gly Met Asp
His Met Asp Gly
His Met Gly Asp
His Pro Cys Cys
His Ser Asp Thr
His Ser Glu Ser
His Ser Ser Glu
His Ser Thr Asp
His Thr Asp Ser
Met Asp Gly His
Met Asp His Gly
Met Gly Asp His
Met Gly His Asp
Met His Asp Gly
Met His Gly Asp
Asn Asp Asn Pro
Asn Asp Pro Asn
Asn Asn Asp Pro
Asn Asn Pro Asp
Asn Pro Asp Asn
Asn Pro Asn Asp
Pro Cys Cys His
Pro Cys His Cys
Pro Asp Asn Asn
Pro His Cys Cys
Pro Asn Asp Asn
Pro Asn Asn Asp
Ser Cys Cys Phe
Ser Cys Phe Cys
Ser Cys Ser Tyr
Ser Cys Tyr Ser
Ser Asp His Thr
Ser Asp Thr His
Ser Glu His Ser
Ser Glu Ser His
Ser Phe Cys Cys
Ser His Asp Thr
Ser His Glu Ser
Ser His Ser Glu
Ser His Thr Asp
Ser Ser Cys Tyr
Ser Ser Glu His
Ser Ser His Glu
Ser Ser Tyr Cys
Ser Thr Asp His
Ser Thr His Asp
Ser Tyr Cys Ser
Ser Tyr Ser Cys
Thr Asp His Ser
Thr Asp Ser His
Thr His Asp Ser
Thr His Ser Asp
Thr Ser Asp His
Thr Ser His Asp
Tyr Ala Cys Cys
Tyr Cys Ala Cys
Tyr Cys Cys Ala
Tyr Cys Ser Ser
Tyr Ser Cys Ser
Tyr Ser Ser Cys
2'-(E)-Feruloyl-3-(arabinosylxylose)
6-o-acetyldaidzin
cis-p-Coumaric acid 4-[apiosyl-(1->2)-glucoside]
3-Hydroxychavicol 1-[rhamnosyl-(1->6)-glucoside]
Eugenol O-[a-L-Arabinofuranosyl-(1->6)-b-D-glucopyranoside]
Valechlorin
a-L-Fucopyranosyl-(1->2)-b-D-galactopyranosyl-(1->2)-D-xylose
7-Hydroxy-4-methylphthalide O-[arabinosyl-(1->6)-glucoside]
Ethanaminium, N, N,N-triethyl-, (T-4)-tetrachloronickelate(2-) (2:1)
2-[(2-cyanoethyl)[p-[(p-nitrophenyl)azo]phenyl]amino]ethyl carbanilate
[bis(4-amino-3,5-dimethylphenyl)-(2,6-dichlorophenyl)methoxy]boronic acid
N-(2-fluorophenyl)-2-[4-methyl-5-[2-(4-methyl-3-nitroanilino)-2-oxoethyl]sulfanyl-1,2,4-triazol-3-yl]acetamide
2-[[4-[(2-cyanoethyl)ethylamino]phenyl]azo]-5-[(4-nitrophenyl)azo]thiophene-3-carbonitrile
ethyl 6-fluoro-1-(4-fluorophenyl)-7-[4-(2-hydroxyethyl)piperazin-1-yl]-4-oxo-1,8-naphthyridine-3-carboxylate
BMS-2
[(1R,2S,3R,4R,5R,6S)-3-benzoyloxy-4-butanoyloxy-2,5,6-trihydroxycyclohexyl] benzoate
ethane-1,2-diol,hexanedioic acid,1-isocyanato-4-[(4-isocyanatophenyl)methyl]benzene
5-(diisopropylamino)-2-[[4-(dimethylamino)phenyl]azo]-3-methyl-1,3,4-thiadiazolium methyl sulphate
3,4-DI-O-ACETYL-1,2-O-ISOPROPYLIDENE-5-O-TOSYL-ALPHA-L-SORBOPYRANSE
POLY(STYRENE-CO-VINYLBENZYL CHLORIDE-CO-DIVINYLBENZENE)
ethylene glycol bis[4-(2-fluorobenzoyl)phenyl] ether
N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]-2-(3-pyridinyl)ethyl]-2-thiophenesulfonamide
n-[(9-beta-d-Ribofuranosyl-2-methylthiopurin-6-yl)carbamoyl]threonine
4-[2-(1,3-dioxo-2-benzo[de]isoquinolinyl)ethyl]-N-(4-methylphenyl)-1-piperazinecarbothioamide
4-[[4-[(Z)-2-cyano-3-(4-methoxyanilino)-3-oxoprop-1-enyl]-2-methoxyphenoxy]methyl]benzoic acid
4-[2-[[3-(4-Methylphenyl)-5-triazolo[1,5-a]quinazolinyl]amino]ethyl]benzenesulfonamide
4-[(diethylamino)sulfonyl]-N-[1-(4,5-dimethyl-6-oxo-1,6-dihydropyrimidin-2-yl)-3-methyl-1H-pyrazol-5-yl]benzamide
Iodofiltic acid (123I)
C1446 - Radiopharmaceutical Compound > C2124 - Radioconjugate
4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide
5-(4-Phenoxyphenyl)-5-(4-Pyrimidin-2-Ylpiperazin-1-Yl)pyrimidine-2,4,6(2h,3h)-Trione
2-(Hydroxymethyl)-6-[[3,4,5-trihydroxy-6-(4-prop-2-enylphenoxy)oxan-2-yl]methoxy]oxane-3,4,5-triol
6-O-ACETYLDAIDZIN
(1S,4aS,11R,12R,12aR)-3-carbamoyl-1-(dimethylazaniumyl)-4a,7,11,12-tetrahydroxy-11-methyl-4,5,6-trioxo-1,4,4a,5,6,11,12,12a-octahydrotetracen-2-olate
O-methyl-4-O-[alpha-L-rhamnopyranosyl-(1->3)-2-O-methyl-alpha-L-rhamnopyranosyl]-hydroxybenzoate
10,14-Dihydroxy-11-methoxy-3,3-dimethyl-12-(3-methyl-2-butenyl)-[1]benzopyrano[5,6-b]xanthen-13(3H)-one
(+-)-chartaceone B
A dihydroxyflavanone that is flavanone substituted by hydroxy groups at positions 5 and 7 and a 6-carboxy-1-phenylhex-1-en-1-yl group at position 6. It has been isolated as a racemate from the bark of Cryptocarya chartacea.
6-[3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl]-3-(2-methoxyphenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine
rac-(6E)-5-(5,7-dihydroxy-4-oxo-2-phenyl-3,4-dihydro-2H-chromen-6-yl)-7-phenylhept-6-enoic acid
3-deoxy-8-O-(3-deoxy-alpha-D-manno-oct-2-ulopyranonosyl)-alpha-D-manno-oct-2-ulopyranosonic acid
4-[3-(2-Furanyl)-4-(3-nitrophenyl)-6-oxo-2,4-dihydropyrrolo[3,4-c]pyrazol-5-yl]benzoic acid ethyl ester
N-(2,2-difluoro-1,3-benzodioxol-5-yl)-2-[2-[2-(4-morpholinyl)-2-oxoethyl]-1-benzimidazolyl]acetamide
2-[[4-(4-methoxyphenyl)-5-(2-phenylethyl)-1,2,4-triazol-3-yl]thio]-N-(phenylmethyl)acetamide
4-(1,3-Dioxo-2-benzo[de]isoquinolinyl)butanoic acid [2-(2-acetylanilino)-2-oxoethyl] ester
1-[2,5-Dimethyl-1-(2-oxolanylmethyl)-3-pyrrolyl]-2-[[5-(4-methoxyanilino)-1,3,4-thiadiazol-2-yl]thio]ethanone
2-[3-[(Z)-(3-cyclopentyl-4-oxo-2-phenylimino-1,3-thiazolidin-5-ylidene)methyl]-2-methylindol-1-yl]acetamide
11-{[(E)-(3,4-dimethoxyphenyl)methylidene]amino}-3-(2-methoxyethyl)-3,11-dihydro-4H-pyrimido[5,4:4,5]pyrrolo[2,3-b]quinoxalin-4-one
N-(2,4-Difluorophenyl)-2-[2-methylimino-4-oxo-3-[(E)-(4-prop-2-enoxyphenyl)methylideneamino]-1,3-thiazolidin-5-yl]acetamide
N-[2-methyl-5-[oxo-[3-(1-oxoprop-2-enylamino)-5-(trifluoromethyl)anilino]methyl]phenyl]-5-isoxazolecarboxamide
2-[(2R,4aS,12aR)-5-methyl-6-oxo-8-[(1-oxo-2-thiophen-2-ylethyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid methyl ester
2-[(2S,4aR,12aS)-5-methyl-6-oxo-8-[(1-oxo-2-thiophen-2-ylethyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid methyl ester
N-[(2S,3R,6R)-6-[2-[(3,5-dichlorobenzoyl)amino]ethyl]-2-(hydroxymethyl)oxan-3-yl]oxane-4-carboxamide
N-[(2R,3R,6S)-6-[2-[(3,5-dichlorobenzoyl)amino]ethyl]-2-(hydroxymethyl)oxan-3-yl]oxane-4-carboxamide
2-[(2S,4aR,12aS)-8-[[(4-chlorophenyl)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid
2-[(2R,4aS,12aR)-8-[[(4-chlorophenyl)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid
methyl 2-[(2R,4aR,12aR)-5-methyl-6-oxo-8-[(2-thiophen-2-ylacetyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetate
N-[(2S,3R,6S)-6-[2-[[(3,5-dichlorophenyl)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
N-[(2R,3S,6R)-6-[2-[[(3,5-dichlorophenyl)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
N-[(2R,3R,6R)-6-[2-[[(3,5-dichlorophenyl)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
N-[(2R,3S,6S)-6-[2-[(3,5-dichlorobenzoyl)amino]ethyl]-2-(hydroxymethyl)oxan-3-yl]oxane-4-carboxamide
N-[(2S,3S,6R)-6-[2-[[(3,5-dichlorophenyl)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
2-[(2R,4aR,12aS)-8-[[(4-chlorophenyl)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid
2-[(2S,4aS,12aS)-8-[[(4-chlorophenyl)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid
2-[(2R,4aR,12aR)-8-[(4-chlorobenzoyl)amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid
methyl 2-[(2S,4aS,12aR)-5-methyl-6-oxo-8-[(2-thiophen-2-ylacetyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetate
2-[(2R,4aR,12aS)-5-methyl-6-oxo-8-[(1-oxo-2-thiophen-2-ylethyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid methyl ester
methyl 2-[(2R,4aS,12aS)-5-methyl-6-oxo-8-[(2-thiophen-2-ylacetyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetate
N-[(2S,3S,6S)-6-[2-[[(3,5-dichlorophenyl)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
2-[(2S,4aR,12aR)-8-[[(4-chlorophenyl)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid
2-[(2S,4aS,12aS)-5-methyl-6-oxo-8-[(1-oxo-2-thiophen-2-ylethyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid methyl ester
[(3aS,4R,9bS)-1-(2-methylphenyl)sulfonyl-8-(2-phenylethynyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
2-[(2S,4aS,12aR)-8-[[(4-chlorophenyl)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid
2-[(2R,4aS,12aS)-8-[[(4-chlorophenyl)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid
2-[(2S,4aR,12aR)-5-methyl-6-oxo-8-[(1-oxo-2-thiophen-2-ylethyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid methyl ester
[(3aR,4S,9bR)-1-(2-methylphenyl)sulfonyl-8-(2-phenylethynyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
[(3aR,4R,9bR)-1-(2-methylphenyl)sulfonyl-8-(2-phenylethynyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
[(3aS,4S,9bS)-1-(2-methylphenyl)sulfonyl-8-(2-phenylethynyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
methyl (1R,9S,10S,11S)-10-(hydroxymethyl)-12-(3-methylphenyl)sulfonyl-6-oxo-5-[(E)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate
methyl (1S,9R,10R,11R)-10-(hydroxymethyl)-12-(3-methylphenyl)sulfonyl-6-oxo-5-[(E)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate
(2E)-2-[(2-fluorophenyl)methylidene]-4-[2-oxo-2-(4-pyridin-2-ylpiperazin-1-yl)ethyl]-1,4-benzoxazin-3-one
1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydro-2H-benzo[G]pteridin-1-ID-10(5H)-YL)-5-O-phosphonato-D-ribitol
Tomudex
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BA - Folic acid analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2021 - Thymidylate Synthase Inhibitor D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents Same as: D01064
lorglumide
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
2-(2-Methoxy-4-prop-2-enylphenoxy)-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]oxane-3,4,5-triol
(+-)-chartaceone A
A racemate composed of equimolar concentrations of chartaceone A1, A2, A3 and A4. It has been isolated from the barks of Cryptocarya chartacea.
chartaceone A
A dihydroxyflavanone that is flavanone substituted by hydroxy groups at positions 5 and 7 and a 6-carboxy-1-phenylhex-1-en-3-yl group at position 6.
5a,11a-dehydrooxytetracycline zwitterion
A zwitterion obtained by transfer of a proton from the 2-hydroxy group to the adjacent tertiary amino group of 5a,11a-dehydrooxytetracycline; major species at pH 7.3.
daidzein 7-(6-O-acetyl-beta-D-glucoside)
A glycosyloxyisoflavone that is daidzein in which the phenolic hydrogen at position 7 has been replaced by a 6-O-acetyl-beta-D-glucosyl residue.
Camlipixant
Camlipixant (BLU-5937) a potent, selective, non-competitive and orally active P2X3 homotrimeric receptor antagonist with an IC50 of 25 nM against hP2X3 homotrimeric. Camlipixant shows potent anti-tussive effect and no taste alteration. Camlipixant can be used for the research of unexplained, refractory chronic cough[1].
CC-90003
CC-90003 is an irreversible and selective inhibitor of ERK 1/2 with antitumor activity.
Quinine (sulfate hydrate)
Quinine sulfate hydrate (2:1:4) is an orally active alkaloid extracted from cinchona bark and can be used in anti-malarial studies. Quinine sulfate hydrate (2:1:4) is a potassium channel inhibitor that inhibits WT mouse Slo3 (KCa5.1) channel currents evoked by voltage pulses to +100?mV with an IC50 of 169 μM[1][2].
5-ethenyl-1-oxo-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,4ah,5h,6h-pyrano[3,4-c]pyran-3-yl 2-methylbutanoate
5-methoxy-3-(4-methoxyphenyl)-8-methyl-7-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}chromen-4-one
(1s,6s,7s,7as)-4-[(acetyloxy)methyl]-7-(chloromethyl)-7-hydroxy-1-[(3-methylbutanoyl)oxy]-1h,6h,7ah-cyclopenta[c]pyran-6-yl 3-methylbutanoate
21'-hydroxy-2',6',6',14',19'-pentamethyl-7',16',18'-trioxaspiro[oxirane-2,11'-pentacyclo[12.6.1.0²,¹².0⁵,¹⁰.0¹⁷,²¹]henicosane]-4',9'-diene-3',8',15',20'-tetrone
5,8,15,18-tetrahydroxy-1,11-bis(methylsulfanyl)-3,13-diazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]icosane-2,12-dione
{3,4,5-trihydroxy-6-[(8-hydroxy-6-methyl-9,10-dioxoanthracen-1-yl)oxy]oxan-2-yl}methyl acetate
methyl (2r)-2-{[3-(2,3-dihydroxy-3-methylbutyl)-4-hydroxyphenyl]methyl}-4-hydroxy-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate
(3r,4s)-3-[(2s,3r)-2,3-dimethyloxirane-2-carbonyloxy]-2,2-dimethyl-8-oxo-3h,4h-pyrano[3,2-g]chromen-4-yl (2s,3r)-2,3-dimethyloxirane-2-carboxylate
10,17-diethyl-1,12,16-trihydroxy-7,18-dimethoxy-4,11-dioxapentacyclo[10.8.0.0³,⁸.0⁹,¹³.0¹⁵,²⁰]icosa-3(8),6,15,17,19-pentaene-5,14-dione
13-(acetyloxy)-4,15-dimethyl-8-oxo-12-(3-oxoprop-1-en-2-yl)-3,7,17-trioxatetracyclo[12.2.1.1⁶,⁹.0²,⁴]octadeca-1(16),9(18),14-trien-10-yl acetate
(z,2z,4e)-4-(methoxyimino)-n-[(1e)-3-[(2e,4s,5r,7s,8r,10s)-4,8,14-trihydroxy-12-oxo-6,11-dioxatricyclo[11.4.0.0⁵,⁷]heptadeca-1(17),2,13,15-tetraen-10-yl]prop-1-en-1-yl]but-2-enimidic acid
(1r,3ar,4r,6as)-4-(2h-1,3-benzodioxol-5-yloxy)-1-(6-methoxy-2h-1,3-benzodioxol-5-yl)-tetrahydro-1h-furo[3,4-c]furan-3a-yl acetate
(5s)-5-[(2s)-5,7-dihydroxy-4-oxo-2-phenyl-2,3-dihydro-1-benzopyran-6-yl]-7-phenylhept-6-enoic acid
(6as)-5-chloro-3-[(1e,3e,5s)-3,5-dimethylhepta-1,3-dien-1-yl]-9-(3-hydroxybutanoyl)-6a-methylfuro[2,3-h]isochromene-6,8-dione
(2r,3s,4s,5s)-2-{3-hydroxy-5-[(11r)-11-hydroxy-12,12-dimethyl-4,13-dioxatricyclo[7.4.0.0³,⁷]trideca-1(9),2,5,7-tetraen-5-yl]phenoxy}oxane-3,4,5-triol
3,4',5-trihydroxy-4-(4-hydroxyphenyl)-6-methoxy-[1,1'-biphenyl]-2-yl 2-phenylacetate
5-methoxy-3-(4-methoxyphenyl)-8-methyl-7-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]chromen-4-one
2-[2-(4-{5-[2-(2,5-dihydroxyphenyl)ethyl]-2-hydroxyphenoxy}phenyl)ethyl]benzene-1,4-diol
1-O-p-coumaroyl-β-D-xylopyranosyl-(1→6)-β-D-glucopyraboside
{"Ingredient_id": "HBIN002928","Ingredient_name": "1-O-p-coumaroyl-\u03b2-D-xylopyranosyl-(1\u21926)-\u03b2-D-glucopyraboside","Alias": "NA","Ingredient_formula": "C20H26O12","Ingredient_Smile": "C1C(C(C(C(O1)OCC2C(C(C(C(O2)OC(=O)C=CC3=CC=C(C=C3)O)O)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "37115","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5,3'-diacetoxy-3,6,7,4'-tetramethoxyflavone
{"Ingredient_id": "HBIN011014","Ingredient_name": "5,3'-diacetoxy-3,6,7,4'-tetramethoxyflavone","Alias": "NA","Ingredient_formula": "C23H22O10","Ingredient_Smile": "CC(=O)OC1=C(C=CC(=C1)C2=C(C(=O)C3=C(C(=C(C=C3O2)OC)OC)OC(=O)C)OC)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5318","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
8-o-β-d-(6'-o-acetyl)glucopyranosylchrysopha-nol
{"Ingredient_id": "HBIN013845","Ingredient_name": "8-o-\u03b2-d-(6'-o-acetyl)glucopyranosylchrysopha-nol","Alias": "NA","Ingredient_formula": "C23H22O10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "401","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}